In Huntington’s disease (HD), alternative splicing alteration emerged as a molecular mechanism in view of individually reported mis-splicing events in neurodegeneration-linked genes such as HTT itself, MAPT and TAF1. This evidence concerns the gene MAPT and juvenile Huntington disease.